By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Antibody announced today it has been selected by SAIC-Frederick to supply antibody and antigen characterization for the National Cancer Institute's proteomics initiative.

Precision will assist SAIC-Frederick with the characterization of newly developed monoclonal antibodies, as well as antigens, as part of the NCI's Clinical Proteomic Technologies for Cancer program. The project will include surface plasmon resonance analysis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.